Cancer cachexia in locally advanced non small cell lung cancer

34 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
Puneeth Iyengar, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, comments on the significance of cancer cachexia, a wasting syndrome affecting approximately half of patients with solid tumors. STK11 mutations, an energy-sensing gene found in 15% of non-small cell lung cancers, and GDF15, a pro-anorexia hormone, have been implicated in cachexia development. This interview took place at 2025 World Conference on Lung Cancer (WCLC) in Barcelona, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Categoria
Oncology
Commenta per primo questo video.

Prossimo